Research Snapshot: Elizabeth Chapman & Dr. Carol Mathews
UF study finds alterations in early visual perceptual processing in people with OCD.
Posted in
MBI News
UF neuroscientists help launch effort to consider universal chemosensory testing
NIH grant supports conference to consider routine monitoring of smell and taste throughout life as part of health care.
Leading brain tumor experts meet for ReMission Summit 2023
Fifth annual ReMission Summit brought together top brain tumor researchers and clinicians to advance new treatments.
Search for a major depression trigger reveals a familiar face: Discovery opens new possibilities for treatments
Scientists at The Wertheim UF Scripps Institute report that a common amino acid can deliver a “slow-down” signal to the brain, likely influencing major depression, anxiety and other mood disorders in some people.
MBI spring e-newsletter: The Brainstorm
Catch up on some of the latest neuroscience and neuromedicine research news around the MBI and beyond.
Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests
Dr. Michalina Janiszewska, Ph.D., a cancer biologist at The Herbert Wertheim UF Scripps Institute, offers insight into glioblastoma mechanisms.
UF neuroscience students bring brain lessons to area public schools
To celebrate Brain Awareness Week, UF neuroscience students brought interactive demonstrations to K-12 students.
FDA approves first ever Friedreich’s ataxia drug treatment
SKYCLARYS was tested and approved by the FDA to treat Friedrich’s ataxia.
Norman Fixel Institute names chief operating officer
Tara Hearns to serve as chief operating officer, overseeing day-to-day operations at the Norman Fixel Institute.
Dr. Michael Jaffee named chair of UF Department of Neurology
Jaffee is the founding director of UF’s Brain Injury, Rehabilitation and Neuroresilience Center and is board certified in neurology, psychiatry, sleep medicine and brain injury medicine with additional certifications in behavioral neurology and neuropsychiatry.
